Clinical measures in transthyretin familial amyloid polyneuropathy.

Clinical measures in transthyretin familial amyloid polyneuropathy.

Item
http://www.wikidata.org/entity/Q45038208
Long-term safety and efficacy of tafamidis for the treatment of hereditary transthyretin amyloid polyneuropathy: results up to 6 years.Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy.Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy.Phenotypic expressions of hereditary Transthyretin Ala97Ser related Amyloidosis (ATTR) in Taiwanese.Transthyretin familial amyloid polyneuropathy: an update.Tafamidis delays neurological progression comparably across Val30Met and non-Val30Met genotypes in transthyretin familial amyloid polyneuropathy.Positive Effectiveness of Tafamidis in Delaying Disease Progression in Transthyretin Familial Amyloid Polyneuropathy up to 2 Years: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
P2860

Clinical measures in transthyretin familial amyloid polyneuropathy.

Item
http://www.wikidata.org/entity/Q45038208
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Clinical measures in transthyretin familial amyloid polyneuropathy.
@en
Clinical measures in transthyretin familial amyloid polyneuropathy.
@nl
type
label
Clinical measures in transthyretin familial amyloid polyneuropathy.
@en
Clinical measures in transthyretin familial amyloid polyneuropathy.
@nl
prefLabel
Clinical measures in transthyretin familial amyloid polyneuropathy.
@en
Clinical measures in transthyretin familial amyloid polyneuropathy.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Clinical measures in transthyretin familial amyloid polyneuropathy.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698